Polaris Pharmaceuticals-KY: Shareholders Approve Lifting of Director Non-Competition Restrictions

Announcement Date: 115/05/16 Spokesperson Date: 115/05/15 Spokesperson Time: 21:15:57 Company Code: 6550 Company Name: Polaris Pharmaceuticals-KY Subject: Announcement of the resolution passed by the company's shareholders' meeting to lift the non-competition restrictions for new directors. Applicable Clause: Clause 21 Date of Event: 115/05/15 Description: 1. Shareholders' meeting resolution date: 115/05/15 2. Names and titles of directors permitted to engage in competitive activities: Directors: Chen Xian-zhe Digital Capital Inc. / Representative: Wei Shao-jun Mai Investment Co., Ltd. / Representative: Cai Gao-zhong 3. Scope of permitted competitive activities: Investing in or operating other businesses that are the same as or similar to the company's business scope. 4. Duration of permitted competitive activities: From the date of this announcement until the end of their term. 5. Resolution details (please explain the voting results in accordance with Article 209 of the Company Act): Passed by resolution at the shareholders' meeting on May 15, 115. 6. If the permitted competitive activities involve businesses in mainland China, director names and titles (for businesses not in mainland China, please enter 'N/A'): N/A 7. Company name and position in the mainland China business: N/A 8. Address of the mainland China business: N/A 9. Business scope of the mainland China business: N/A 10. Impact on the company's financial and business operations: N/A 11. If directors invest in mainland China businesses, investment amount and shareholding ratio: N/A 12. Other matters to be noted: None